Preclinical and Clinical Aspects of Pharmacovigilance

Learn about preclinical safety studies and safety monitoring in clinical phase I, II and III studies

Register Download Material
  • 8. Jun 2021

3 days course

English

18.000,- DKK ex VAT
(app. 2.420,- EUR ex VAT)
50% DISCOUNT FOR PUBLIC INSTITUTIONS

Home > Courses > Preclinical and Clinical Aspects of Pharmacovigilance

Module 5  

Summary

This course will help you understand the preclinical and clinical aspects of pharmacovigilance, including preclinical safety studies. You will also learn about decisions for safety margins and first-dose-in-man, safety principles in phase I, II and III studies, and regulations for safety assessments.

After the course, you will be able to analyze the different pre-application tasks related to preparing clinical study protocols, annual safety reports (SUSARs), integrated clinical study reports and scientific advice in relation to the preparation of clinical trial applications (e.g. endpoints, statistical power, safety parameters, etc.) as well as the pre-application tasks related to conducting clinical studies.

The course is offered every 2 years.

Keywords

  • Pre-clinical Safety Studies
  • Drug Development
  • Clinical Safety Studies
  • Risk Assessment
  • Pharmacovigilance in Clinical Trials
  • Drug Safety
  • Regulatory Affairs
  • Communication with Regulatory Authorities

Course calendar

Start 8. Jun 2021
Registration deadline 1. Jun 2021
8. Jun 20219:00 - 16:00
9. Jun 20219:00 - 16:00
10. Jun 20219:00 - 16:00

Related exams

Start 17. Aug 2021
Registration deadline 10. Aug 2021
17. Aug 20219:00 - 12:00

What you will learn

 

  1. Why preclinical safety studies are done and what preclinical data can be used for in safety assessments
  2. The rationale behind dose selection for first-dose-in-man trials and the reasoning behind decisions for safety margins
  3. The principles of safety monitoring in clinical phase I, II and III studies and regulations for the assessment and monitoring of safety issues in clinical studies
  4. How pharmacovigilance units can co-operate with regulatory authorities
  5. How to share knowledge on preclinical and clinical aspects of pharmacovigilance

What your company will get

  1. A safety and pharmacovigilance professional who understands why preclinical safety studies are done and what preclinical data can be used for in safety assessments
  2. A safety and pharmacovigilance professional who understands the relationship between pharmacovigilance and the processes of application and registration
  3. A safety and pharmacovigilance professional that can independently analyze and evaluate the steps in regulating drug safety
  4. A safety and pharmacovigilance professional who can provide valuable input to all other team members working with preclinical and clinical aspects of pharmacovigilance
Available start dates
Download Material

Registration quick facts

You can pay by credit card or by invoice. We charge the amount shortly after you register. If you cancel your registration more than 30 days prior to the course, you will receive a full refund. Read our cancellation policy.

Yes, if you experience any technical problems, please call us at + 45 39 27 60 60, or send us an email at contact@atriumcph.com

If you cancel your registration more than 30 days prior to the course, you will receive a full refund. If you get sick and cannot attend the course, you may hand over the seat to a colleague, who will then have to register for the course on our website prior to course start. If the registration is closed, please send us full name, email, phone and title of your colleague to bfl@atriumcph.com. Read our cancellation policy.

Show allShow fewer Faqs

This course is a part of this programme

Pharmacovigilance Diploma

An international training programme ... Read more

WANT TO KNOW MORE ABOUT THIS COURSE?

Contact Client Manager Ida Salicath at +45 39 15 09 46

Send an email

 

You may also be interested in these courses